Structures and mechanism of action of Comp-NPs for the diagnosis by imaging and treatment of tumors by multimodal photodynamic therapy and immunotherapy. a) Chemical structures of a polymer incorporating a chromophore for imaging upon irradiation at 808?nm (P1) or a photosensitizer for PDT upon irradiation at 650?nm (P2). b) Self-assembly of the polymers into the nanoparticles NP1 and NP2. The theranostic nanoparticle formulation Comp-NPs is generated by mixing NP1 and NP2. c) Biological mechanism of action of Comp-NPs by combined photodynamic therapy and immunotherapy.
Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-40826-5
An international research team headed by Dr. Johannes Karges of the Faculty of Chemistry and Biochemistry at Ruhr University Bochum, Germany, has developed nanoparticles that accumulate in cancer cells and eliminate them after being photoactivated.
In addition, they label them in such a way that immune cells learn to eliminate similar cells throughout the body. This means that even undetected metastases can be treated. The researchers presented their findings in the journal Nature Communications of 2 September 2023.
The malicious nature of cancers means that they spread throughout the body: cells from the primary tumor grow into surrounding tissue and travel through the bloodstream and lymphatic system to distant organs, where they form secondary metastatic tumors. “While we now have effective methods to combat primary tumors, metastases are still very difficult to treat,” explains Johannes Karges. “Ninety percent of people who die from cancer die from metastases and tumor regression, not from the primary tumor.”
Together with an international team, he’s developed a drug packaged in nanoparticles that are administered into the bloodstream. “Tumors grow rapidly and uncontrollably, and their tissue is therefore leaky,” he describes. “Unlike in healthy tissues, the nanoparticles therefore accumulate in them easily.” This also means that the particles preferentially accumulate in tumor cells.
Step one: treating a known tumor
At the time of administration, the drug is still ineffective. It only takes effect when activated with light. If there are sufficient nanoparticles in a detected tumor, they can be activated by irradiation with light, for example during surgery. After this energy supply, the active species ensures that immunogenic cell death occurs: the tumor cells containing the photoactivated nanoparticles are eliminated, and the tumor treated by this method disappears.
Step two: sending immune cells on a search
But that’s not all: the nanoparticles and their light-induced effect cause massive oxidative stress in the endoplasmic reticulum of the cells of the treated tumor. “This alerts the body’s own immune system,” explains Johannes Karges. “The immune cells recognize that something is going completely wrong in cells of this type, and that such cells therefore need to be eliminated.” This applies not only to the cells of the photo-treated tumor itself, but to all cells of the same kind throughout the body. “Accordingly, the immune system starts looking for further metastases and renders them harmless,” says Johannes Karges.
The research team proved this active principle in experiments on cancer cells and in animal models. They applied it to effectively treat mice that had been implanted with cells from metastasized and incurable human tumors. “Now, we’re looking for industrial partners who will help us undertake more in-depth studies,” says Johannes Karges. He expects that several more years of development work will be needed before the technology can be widely used in clinical applications.
Original Article: New compound unleashes the immune system on metastases
More from: Ruhr University Bochum
The Latest Updates from Bing News
Go deeper with Bing News on:
Treating metastases
- BGU researchers use novel chemo delivery to kill colorectal cancer liver metastases
When possible, the metastatic tumors are removed by surgery ... “We also examined the option of treating mice with a polymer without the cytotoxic drug as a preventive therapy, to try to stop the ...
- Conference MDAngle: AUA 2024 Metastatic Prostate Cancer
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will impact their patients.
- Dog Eats Chocolate Bar as Final Treat Before Being Put to Sleep
A man gave his dying dog a chocolate bar – a treat dogs love but that is toxic to them – as a final gesture of love before she was put to sleep on April 23.Footage recorded by Miller Hurtado Toro ...
- Definitive Therapy to the Primary Site Improves Survival in Brain-Only Metastatic NSCLC
Definitive treatment to the primary site improves overall and cancer-specific survival among patients with brain-only NSCLC metastases, a recent retrospective study shows.
- First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer
The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer.
Go deeper with Bing News on:
Undetected metastases
- Health Canada approves Merck’s Keytruda for gastric cancer treatment
Health Canada has approved Merck & Co Inc (MSD)’s Keytruda (pembrolizumab), an anti-programmed cell death protein 1 (PD-1) therapy.
- Red flag signs of silent killer that can grow for years without symptoms
Killing around 16,800 people every year in the UK - that's 46 every day - it is the second biggest cancer killer in the country but it can go undetected for years ...
- Gene Network Interactions Shed Insight into Breast Cancer Onset and Development
A new study has identified differential gene-network changes characteristic of the three most prevalent molecular subtypes of breast cancer, Luminal A, Luminal B, and the highly metastatic Basal-like ...
- AI traces mysterious metastatic cancers to their source
Mahmood has previously used AI to predict the origin of cancers from tissue samples 2, and other teams have used genomic data. Combining the three data sources — cells, tissue and genomics — could ...
- New Prostate Cancer Treatments Offer Hope for Advanced Cases
Major discoveries during the past 10 years have transformed prostate cancer treatment, enabling it to proceed even for the most advanced form of the disease ...